{"id":338692,"date":"2026-11-04T11:38:37","date_gmt":"2026-11-04T06:08:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=338692"},"modified":"2026-11-04T11:38:37","modified_gmt":"2026-11-04T06:08:37","slug":"oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/","title":{"rendered":"3 Oleochemical Additives Leader, Generics and Active Ingredients Company and Integrated Apparel Maker Stocks With a Strong Future Roadmap: Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill: ROE of 11.1% to 15.7% and FY22 to FY26 revenue CAGR of 6.8% to 12.3%. Prices as of 3 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three additive, generic drug and apparel maker stocks to watch are Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill. Their return on equity ranges from 11.1% to 15.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.8% to 12.3%. Fine Organic Industries has the highest return on equity at 15.7%, while Dr. Reddy&#8217;s Laboratories has the fastest revenue growth at 12.3% a year. Prices are based on the 3 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Additive, generic drug and apparel maker stocks give investors a way to track businesses that sit close to everyday demand in India. Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill cover an oleochemical additives leader, a generics company and an integrated apparel maker.<\/p>\n<p>This list covers three additive, generic drug and apparel maker stocks with complete current figures: Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill. Every figure comes from the latest reported financials and the 3 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#What_Are_Additive_Generic_Drug_and_Apparel_Maker_Stocks\" title=\"What Are Additive, Generic Drug and Apparel Maker Stocks?\">What Are Additive, Generic Drug and Apparel Maker Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Additive_Generic_Drug_and_Apparel_Maker_Stocks_at_a_Glance\" title=\"Additive, Generic Drug and Apparel Maker Stocks at a Glance\">Additive, Generic Drug and Apparel Maker Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Why_Do_Additive_Generic_Drug_and_Apparel_Maker_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Additive, Generic Drug and Apparel Maker Stocks Have a Strong Roadmap in India?\">Why Do Additive, Generic Drug and Apparel Maker Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Why_Fine_Organic_Industries_Features_Among_These_Additive_Generic_Drug_and_Apparel_Maker_Stocks\" title=\"Why Fine Organic Industries Features Among These Additive, Generic Drug and Apparel Maker Stocks\">Why Fine Organic Industries Features Among These Additive, Generic Drug and Apparel Maker Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Why_Dr_Reddys_Laboratories_Features_Among_These_Additive_Generic_Drug_and_Apparel_Maker_Stocks\" title=\"Why Dr. Reddy&#8217;s Laboratories Features Among These Additive, Generic Drug and Apparel Maker Stocks\">Why Dr. Reddy&#8217;s Laboratories Features Among These Additive, Generic Drug and Apparel Maker Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Why_KPR_Mill_Features_Among_These_Additive_Generic_Drug_and_Apparel_Maker_Stocks\" title=\"Why KPR Mill Features Among These Additive, Generic Drug and Apparel Maker Stocks\">Why KPR Mill Features Among These Additive, Generic Drug and Apparel Maker Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Fine_Organic_Industries_vs_Dr_Reddys_Laboratories_vs_KPR_Mill_on_Key_Financials\" title=\"Fine Organic Industries vs Dr. Reddy&#8217;s Laboratories vs KPR Mill on Key Financials\">Fine Organic Industries vs Dr. Reddy&#8217;s Laboratories vs KPR Mill on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Key_Risks_to_Check_Before_Investing_in_Additive_Generic_Drug_and_Apparel_Maker_Stocks\" title=\"Key Risks to Check Before Investing in Additive, Generic Drug and Apparel Maker Stocks\">Key Risks to Check Before Investing in Additive, Generic Drug and Apparel Maker Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Final_Thoughts_on_Additive_Generic_Drug_and_Apparel_Maker_Stocks\" title=\"Final Thoughts on Additive, Generic Drug and Apparel Maker Stocks\">Final Thoughts on Additive, Generic Drug and Apparel Maker Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#What_are_additive_generic_drug_and_apparel_maker_stocks\" title=\"What are additive, generic drug and apparel maker stocks?\">What are additive, generic drug and apparel maker stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Which_additive_generic_drug_and_apparel_maker_stocks_are_covered_in_this_list\" title=\"Which additive, generic drug and apparel maker stocks are covered in this list?\">Which additive, generic drug and apparel maker stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Why_do_additive_generic_drug_and_apparel_maker_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do additive, generic drug and apparel maker stocks have a strong future roadmap in India?\">Why do additive, generic drug and apparel maker stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#How_has_Fine_Organic_Industries_performed_financially\" title=\"How has Fine Organic Industries performed financially?\">How has Fine Organic Industries performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#How_has_Dr_Reddys_Laboratories_performed_financially\" title=\"How has Dr. Reddy&#8217;s Laboratories performed financially?\">How has Dr. Reddy&#8217;s Laboratories performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#How_has_KPR_Mill_performed_financially\" title=\"How has KPR Mill performed financially?\">How has KPR Mill performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#What_risks_should_investors_check_before_buying_additive_generic_drug_and_apparel_maker_stocks\" title=\"What risks should investors check before buying additive, generic drug and apparel maker stocks?\">What risks should investors check before buying additive, generic drug and apparel maker stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/oleochemical-additives-leader-generics-and-active-ingredients-company-and-integrated-apparel-maker-stocks-roadmap-quayside-list\/#Is_this_list_of_additive_generic_drug_and_apparel_maker_stocks_investment_advice\" title=\"Is this list of additive, generic drug and apparel maker stocks investment advice?\">Is this list of additive, generic drug and apparel maker stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Additive_Generic_Drug_and_Apparel_Maker_Stocks\"><\/span><strong>What Are Additive, Generic Drug and Apparel Maker Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Additive, generic drug and apparel maker stocks are listed companies that make additives for food, plastics and cosmetics, supply generics and active ingredients in India and global markets, and spin yarn, knit fabric and stitch garments for global brands. Their earnings depend on export orders and customer industries.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Additive_Generic_Drug_and_Apparel_Maker_Stocks_at_a_Glance\"><\/span><strong>Additive, Generic Drug and Apparel Maker Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/fineorg\/fine-organic-industries-ltd-share-price-today\">Fine Organic Industries<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,089<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16,561<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/drreddy\/dr-reddy's-laboratories-ltd-share-price-today\">Dr. Reddy&#8217;s Laboratories<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,368.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">103,667<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.20<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/kprmill\/kpr-mill-ltd-share-price-today\">KPR Mill<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,160<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34,974<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.10<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Dr. Reddy&#8217;s Laboratories trades at a P\/E below the industry P\/E, while Fine Organic Industries and KPR Mill trade above it, which reflects the growth the market already expects. Readers comparing additive, generic drug and apparel maker stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in additive, generic drug and apparel maker stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Additive_Generic_Drug_and_Apparel_Maker_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Additive, Generic Drug and Apparel Maker Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Additive, generic drug and apparel maker stocks have a strong roadmap in India because growing demand for specialty additives, steady use of generics and strong export orders for garments keep widening the market for these export linked companies.<\/p>\n<ul>\n<li><strong>Additives.<\/strong> Food and plastics makers use specialty inputs.<\/li>\n<li><strong>Generics.<\/strong> Medicines reach North America, Europe and India.<\/li>\n<li><strong>Garments.<\/strong> Integrated mills serve global brands.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Fine_Organic_Industries_Features_Among_These_Additive_Generic_Drug_and_Apparel_Maker_Stocks\"><\/span><strong>Why Fine Organic Industries Features Among These Additive, Generic Drug and Apparel Maker Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the additive, generic drug and apparel maker stocks on this list, Fine Organic Industries is a leading maker of oleochemical-based additives used in food, plastics, cosmetics and coatings, selling to customers in India and overseas.<\/p>\n<p>The company has a return on equity of 15.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 16,561 crore. The stock trades at a P\/E of 37.8, above the industry P\/E of 35.1.<\/p>\n<p>Revenue rose from Rs 1,909 crore in FY22 to Rs 2,482 crore in FY26, a compound annual growth rate of 6.8%. Net profit grew from Rs 260 crore in FY22 to Rs 417 crore in FY26, which works out to a compound annual growth rate of 12.6%. In the June 2026 quarter, revenue grew 14.4% year on year to Rs 718 crore, while net profit rose 18.0% to Rs 138 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company holds a strong position in additives for plastics and food products and is adding capacity to meet export demand. A large net cash position and low debt give flexibility to invest in new product lines.<\/p>\n<p><strong>What to watch:<\/strong> Monitor raw material prices, export demand and the pace of new capacity addition.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Dr_Reddys_Laboratories_Features_Among_These_Additive_Generic_Drug_and_Apparel_Maker_Stocks\"><\/span><strong>Why Dr. Reddy&#8217;s Laboratories Features Among These Additive, Generic Drug and Apparel Maker Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the specialty chemical, pharma and textile shares on this list, Dr. Reddy&#8217;s Laboratories is a Hyderabad-based pharmaceutical company that makes generics, active ingredients and branded products for India and global markets, with a large presence in North America and Europe.<\/p>\n<p>Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%.<\/p>\n<p>The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P\/E of 32.6, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.<\/p>\n<p><strong>What to watch:<\/strong> Monitor launches of complex generics and the progress of biosimilar programmes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_KPR_Mill_Features_Among_These_Additive_Generic_Drug_and_Apparel_Maker_Stocks\"><\/span><strong>Why KPR Mill Features Among These Additive, Generic Drug and Apparel Maker Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, KPR Mill is a Coimbatore-based, vertically integrated apparel maker that spins yarn, knits fabric and stitches garments for global brands. It also runs sugar and ethanol operations and a growing retail business.<\/p>\n<p>In the June 2026 quarter, revenue grew 9.3% year on year to Rs 1,970 crore, while net profit rose 21.6% to Rs 259 crore. Revenue rose from Rs 4,910 crore in FY22 to Rs 6,784 crore in FY26, a compound annual growth rate of 8.4%.<\/p>\n<p>Net profit grew from Rs 815 crore in FY25 to Rs 866 crore in FY26, a rise of 6.3%. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 34,974 crore. The stock trades at a P\/E of 38.3, above the industry P\/E of 33.8.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding garment and fabric capacity and deepening ties with large international apparel buyers. Its control over each step from yarn to garment supports delivery speed and quality.<\/p>\n<p><strong>What to watch:<\/strong> Track garment export orders, capacity additions and the progress of the retail business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fine_Organic_Industries_vs_Dr_Reddys_Laboratories_vs_KPR_Mill_on_Key_Financials\"><\/span><strong>Fine Organic Industries vs Dr. Reddy&#8217;s Laboratories vs KPR Mill on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three additive, generic drug and apparel maker stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Fine Organic Industries<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,909<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,482<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">417<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dr. Reddy&#8217;s Laboratories<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22,030<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35,059<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,158<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">KPR Mill<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,910<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,784<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.4%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">866<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.8%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Fine Organic Industries posts the highest return on equity in this group at 15.7%. Dr. Reddy&#8217;s Laboratories combines the largest FY26 revenue at Rs 35,059 crore with the fastest revenue growth, a 12.3% compound annual rate. A useful habit with additive, generic drug and apparel maker stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Additive_Generic_Drug_and_Apparel_Maker_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Additive, Generic Drug and Apparel Maker Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these additive, generic drug and apparel maker stocks, the main points are: Long-term specialty chemical, pharma and textile shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Currency moves.<\/strong> Export earnings move with the rupee.<\/li>\n<li><strong>Pricing pressure.<\/strong> Generic prices can change by market.<\/li>\n<li><strong>Valuation levels.<\/strong> Some of these companies trade at high earnings multiples, so growth must continue to justify them.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter additive, generic drug and apparel maker stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Additive_Generic_Drug_and_Apparel_Maker_Stocks\"><\/span><strong>Final Thoughts on Additive, Generic Drug and Apparel Maker Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Additive, generic drug and apparel maker stocks work best when investors track growth, valuation and return on equity side by side. Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill each have a clear plan to grow. Based on the 3 November 2026 close, Fine Organic Industries trades at Rs 5,089, Dr. Reddy&#8217;s Laboratories at Rs 1,368.3 and KPR Mill at Rs 1,160. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these additive, generic drug and apparel maker stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track additive, generic drug and apparel maker stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_additive_generic_drug_and_apparel_maker_stocks\"><\/span><strong>What are additive, generic drug and apparel maker stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Additive, generic drug and apparel maker stocks are listed companies that make additives for food, plastics and cosmetics, supply generics and active ingredients in India and global markets, and spin yarn, knit fabric and stitch garments for global brands. Their earnings depend on export orders and customer industries. This list looks at three of them, Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill, using reported FY22 to FY26 financials and the 3 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_additive_generic_drug_and_apparel_maker_stocks_are_covered_in_this_list\"><\/span><strong>Which additive, generic drug and apparel maker stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill. Based on the 3 November 2026 close, Fine Organic Industries traded at Rs 5,089, Dr. Reddy&#8217;s Laboratories at Rs 1,368.3 and KPR Mill at Rs 1,160. Their return on equity ranges from 11.1% to 15.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.8% to 12.3%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_additive_generic_drug_and_apparel_maker_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do additive, generic drug and apparel maker stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Additive, generic drug and apparel maker stocks have a strong roadmap in India because growing demand for specialty additives, steady use of generics and strong export orders for garments keep widening the market for these export linked companies. The main drivers are as follows. Additives. Food and plastics makers use specialty inputs. Generics. Medicines reach North America, Europe and India. Garments. Integrated mills serve global brands. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Fine_Organic_Industries_performed_financially\"><\/span><strong>How has Fine Organic Industries performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,909 crore in FY22 to Rs 2,482 crore in FY26, a compound annual growth rate of 6.8%. Net profit grew from Rs 260 crore in FY22 to Rs 417 crore in FY26, which works out to a compound annual growth rate of 12.6%. In the June 2026 quarter, revenue grew 14.4% year on year to Rs 718 crore, while net profit rose 18.0% to Rs 138 crore. The company has a return on equity of 15.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 16,561 crore. The stock trades at a P\/E of 37.8, above the industry P\/E of 35.1. Looking ahead, the company holds a strong position in additives for plastics and food products and is adding capacity to meet export demand. A large net cash position and low debt give flexibility to invest in new product lines.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Dr_Reddys_Laboratories_performed_financially\"><\/span><strong>How has Dr. Reddy&#8217;s Laboratories performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%. The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P\/E of 32.6, below the industry P\/E of 36.0. Looking ahead, the company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_KPR_Mill_performed_financially\"><\/span><strong>How has KPR Mill performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 4,910 crore in FY22 to Rs 6,784 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 815 crore in FY25 to Rs 866 crore in FY26, a rise of 6.3%. In the June 2026 quarter, revenue grew 9.3% year on year to Rs 1,970 crore, while net profit rose 21.6% to Rs 259 crore. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 34,974 crore. The stock trades at a P\/E of 38.3, above the industry P\/E of 33.8. Looking ahead, the company is adding garment and fabric capacity and deepening ties with large international apparel buyers. Its control over each step from yarn to garment supports delivery speed and quality.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_additive_generic_drug_and_apparel_maker_stocks\"><\/span><strong>What risks should investors check before buying additive, generic drug and apparel maker stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying additive, generic drug and apparel maker stocks. Currency moves. Export earnings move with the rupee. Pricing pressure. Generic prices can change by market. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_additive_generic_drug_and_apparel_maker_stocks_investment_advice\"><\/span><strong>Is this list of additive, generic drug and apparel maker stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 3 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are additive, generic drug and apparel maker stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Additive, generic drug and apparel maker stocks are listed companies that make additives for food, plastics and cosmetics, supply generics and active ingredients in India and global markets, and spin yarn, knit fabric and stitch garments for global brands. Their earnings depend on export orders and customer industries. This list looks at three of them, Fine Organic Industries, Dr. Reddy's Laboratories and KPR Mill, using reported FY22 to FY26 financials and the 3 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which additive, generic drug and apparel maker stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Fine Organic Industries, Dr. Reddy's Laboratories and KPR Mill. Based on the 3 November 2026 close, Fine Organic Industries traded at Rs 5,089, Dr. Reddy's Laboratories at Rs 1,368.3 and KPR Mill at Rs 1,160. Their return on equity ranges from 11.1% to 15.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.8% to 12.3%.\"}},{\"@type\":\"Question\",\"name\":\"Why do additive, generic drug and apparel maker stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Additive, generic drug and apparel maker stocks have a strong roadmap in India because growing demand for specialty additives, steady use of generics and strong export orders for garments keep widening the market for these export linked companies. The main drivers are as follows. Additives. Food and plastics makers use specialty inputs. Generics. Medicines reach North America, Europe and India. Garments. Integrated mills serve global brands. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Fine Organic Industries performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,909 crore in FY22 to Rs 2,482 crore in FY26, a compound annual growth rate of 6.8%. Net profit grew from Rs 260 crore in FY22 to Rs 417 crore in FY26, which works out to a compound annual growth rate of 12.6%. In the June 2026 quarter, revenue grew 14.4% year on year to Rs 718 crore, while net profit rose 18.0% to Rs 138 crore. The company has a return on equity of 15.7%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 16,561 crore. The stock trades at a P\/E of 37.8, above the industry P\/E of 35.1. Looking ahead, the company holds a strong position in additives for plastics and food products and is adding capacity to meet export demand. A large net cash position and low debt give flexibility to invest in new product lines.\"}},{\"@type\":\"Question\",\"name\":\"How has Dr. Reddy's Laboratories performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 22,030 crore in FY22 to Rs 35,059 crore in FY26, a compound annual growth rate of 12.3%. Net profit grew from Rs 2,182 crore in FY22 to Rs 4,158 crore in FY26, which works out to a compound annual growth rate of 17.5%. The company has a return on equity of 11.1%, a debt to equity ratio of 0.20 and a market capitalisation of Rs 103,667 crore. The stock trades at a P\/E of 32.6, below the industry P\/E of 36.0. Looking ahead, the company is widening its product pipeline with complex generics, biosimilars and consumer health, while its domestic business adds steady growth. Investment in research supports a stream of new launches.\"}},{\"@type\":\"Question\",\"name\":\"How has KPR Mill performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 4,910 crore in FY22 to Rs 6,784 crore in FY26, a compound annual growth rate of 8.4%. Net profit grew from Rs 815 crore in FY25 to Rs 866 crore in FY26, a rise of 6.3%. In the June 2026 quarter, revenue grew 9.3% year on year to Rs 1,970 crore, while net profit rose 21.6% to Rs 259 crore. The company has a return on equity of 15.2%, a debt to equity ratio of 0.10 and a market capitalisation of Rs 34,974 crore. The stock trades at a P\/E of 38.3, above the industry P\/E of 33.8. Looking ahead, the company is adding garment and fabric capacity and deepening ties with large international apparel buyers. Its control over each step from yarn to garment supports delivery speed and quality.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying additive, generic drug and apparel maker stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying additive, generic drug and apparel maker stocks. Currency moves. Export earnings move with the rupee. Pricing pressure. Generic prices can change by market. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of additive, generic drug and apparel maker stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 3 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Additive, Generic Drug and Apparel Maker Stocks with a strong future roadmap: Fine Organic Industries, Dr. Reddy&#8217;s Laboratories and KPR Mill. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.<\/p>\n","protected":false},"author":28,"featured_media":338690,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[19143,3803,7377,14108,19700,10629,19702,18030,19701,19109],"class_list":["post-338692","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-additive","tag-best-stocks","tag-dr-reddys-laboratories","tag-fine-organic-industries","tag-generic-drug-and-apparel-maker-stocks","tag-kpr-mill","tag-medicine-and-yarn-stocks","tag-oleochemical","tag-pharma-and-textile-shares","tag-specialty-chemical"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["338690"],"rank_math_title":["Additive, Generic Drug and Apparel Stocks"],"rank_math_description":["Compare 3 additive, generic drug and apparel maker stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 3 Nov 2026."],"rank_math_focus_keyword":["additive, generic drug and apparel maker stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-oleochemical-additives-leader-generics-and-active-ingredients-company-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/338692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=338692"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/338692\/revisions"}],"predecessor-version":[{"id":338693,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/338692\/revisions\/338693"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/338690"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=338692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=338692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=338692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}